new quality-of-life data for tucatinib in her2 breast cancer
Published 3 years ago • 65 plays • Length 5:08Download video MP4
Download video MP3
Similar videos
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
3:25
new data comparing adjuvant t-dm1 vs trastuzumab for her2 breast cancer
-
4:58
tucatinib and hrqol among patients with her2 metastatic breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
3:59
emerging data for the treatment of her2 mbc
-
0:56
revolutionizing her2-positive breast cancer treatment: unveiling breakthrough results!
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer